Literature DB >> 24707149

Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.

Xu-Guang Jiao1, Jing-Yu Deng1, Ru-Peng Zhang1, Liang-Liang Wu1, Li Wang1, Hong-Gen Liu1, Xi-Shan Hao1, Han Liang1.   

Abstract

AIM: To elucidate the potential impact of examined lymph nodes (eLNs) on long-term survival of node-negative gastric cancer patients after curative surgery.
METHODS: A total of 497 node-negative gastric cancer patients who underwent curative gastrectomy between January 2000 and December 2008 in our center were enrolled in this study. Patients were divided into 4 groups according to eLNs through cut-point analysis. Clinicopathological features were compared between ≤ 15 eLNs group and > 15 eLNs group and potential prognostic factors were analyzed. The Log-rank test was used to assess statistical differences between the groups. Independent prognostic factors were identified using the Cox proportional hazards regression model. Stratified analysis was performed to investigate the impact of eLNs on patient survival in each stage. Overall survival was also compared among the four groups. Finally, we explored the recurrent sites associated with eLNs.
RESULTS: Patients with eLNs > 15 had a better survival compared with those with eLNs ≤ 15 for the entire cohort. By the multivariate survival analysis, we found that the depth of invasion and the number of eLNs were the independent predictors of overall survival (OS) of patients with node-negative gastric cancer. According to the cut-point analysis, T2-T4 patients with 11-15 eLNs had a significantly longer mean OS than those with 4-10 eLNs or 1-3 eLNs. Patients with ≤ 15 eLNs were more likely to experience locoregional and peritoneal recurrence than those with > 15 eLNs.
CONCLUSION: Number of eLNs could predict the prognosis of node-negative gastric cancer, and dissection of > 15 eLNs is recommended during lymphadenectomy so as to improve the long-term survival.

Entities:  

Keywords:  Examined lymph nodes; Gastric carcinoma; Node-negative; Prognosis

Mesh:

Year:  2014        PMID: 24707149      PMCID: PMC3974533          DOI: 10.3748/wjg.v20.i13.3640

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  JGCA (The Japan Gastric Cancer Association). Gastric cancer treatment guidelines.

Authors:  Y Shimada
Journal:  Jpn J Clin Oncol       Date:  2004-01       Impact factor: 3.019

2.  Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.

Authors:  Jingyu Deng; Han Liang; Dan Sun; Rupeng Zhang; Hongjie Zhan; Xiaona Wang
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

3.  Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan.

Authors:  Yuko Kitagawa; Hiroya Takeuchi; Yu Takagi; Shoji Natsugoe; Masanori Terashima; Nozomu Murakami; Takashi Fujimura; Hironori Tsujimoto; Hideki Hayashi; Nobunari Yoshimizu; Akinori Takagane; Yasuhiko Mohri; Kazuhito Nabeshima; Yoshikazu Uenosono; Shinichi Kinami; Junichi Sakamoto; Satoshi Morita; Takashi Aikou; Koichi Miwa; Masaki Kitajima
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

4.  Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.

Authors:  Taeil Son; Woo Jin Hyung; Joong Ho Lee; Yoo Min Kim; Hyoung-Il Kim; Ji Yeong An; Jae-Ho Cheong; Sung Hoon Noh
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

5.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

Authors:  Jin-Pok Kim; Joo-Ho Lee; Soo-Jin Kim; Hang-Jong Yu; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  1998-03       Impact factor: 7.370

6.  Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma.

Authors:  H Katai; K Yoshimura; K Maruyama; M Sasako; T Sano
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

7.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

8.  Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Hui-Shan Lu
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

9.  The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.

Authors:  Jong-Han Kim; Joong-Min Park; Cheol-Woong Jung; Sung-Soo Park; Seung-Joo Kim; Young-Jae Mok; Chong-Suk Kim; Yang-Suk Chae; Jeoung-Won Bae
Journal:  J Surg Oncol       Date:  2008-02-01       Impact factor: 3.454

10.  Impact of lymphovascular invasion in patients with stage I gastric cancer.

Authors:  Chikara Kunisaki; Hirochika Makino; Jun Kimura; Ryo Takagawa; Takashi Kosaka; Hidetaka A Ono; Hirotoshi Akiyama; Tadao Fukushima; Yutaka Nagahori; Masazumiu Takahashi
Journal:  Surgery       Date:  2009-10-30       Impact factor: 3.982

View more
  24 in total

1.  The Clinical Significance of Lymphovascular Invasion in Gastric Cancer.

Authors:  Hirohito Fujikawa; Keisuke Koumori; Hayato Watanabe; Kazuki Kano; Yyta Shimoda; Toru Aoyama; Takanobu Yamada; Tamagawa Hiroshi; Naoto Yamamoto; Haruhiko Cho; Manabu Shiozawa; Takaki Yoshikawa; Souichiro Morinaga; Yasushi Rino; Munetaka Masuda; Takashi Ogata; Takashi Oshima
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Clinical significance of lymphadenectomy in patients with gastric cancer.

Authors:  Dezső Tóth; János Plósz; Miklós Török
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

3.  Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better?

Authors:  Jun-Te Hsu; Puo-Hsien Le; Chia-Jung Kuo; Ta-Sen Yeh; Yi-Yin Jan
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-07

4.  Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.

Authors:  Yinping Dong; Yiran Qiu; Jingyu Deng; Wei Wang; Zhe Sun; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-07       Impact factor: 4.553

5.  Number of Examined Lymph Nodes as a Risk Factor for Recurrence in pT1N+ or pT2-3N0 Gastric Cancer.

Authors:  Masato Nishimuta; Junichi Arai; Keiko Hamasaki; Yasumasa Hashimoto; Takashi Nonaka; Tetsuro Tominaga; Shosaburo Oyama; Toru Yasutake; Terumitsu Sawai; Takeshi Nagayasu
Journal:  Cancer Diagn Progn       Date:  2022-09-03

6.  Comparison of robotic- and laparoscopic-assisted gastrectomy in advanced gastric cancer: updated short- and long-term results.

Authors:  Yunhe Gao; Hongqing Xi; Zhi Qiao; Jiyang Li; Kecheng Zhang; Tianyu Xie; Weisong Shen; Jianxin Cui; Bo Wei; Lin Chen
Journal:  Surg Endosc       Date:  2018-07-16       Impact factor: 4.584

Review 7.  Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors.

Authors:  Yanming Zhou; Feng Yu; Lupeng Wu; Feng Ye; Leilei Zhang; Yumin Li
Journal:  Med Sci Monit       Date:  2015-07-02

8.  Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.

Authors:  Chen Jian-Hui; Cai Shi-Rong; Wu Hui; Chen Si-le; Xu Jian-Bo; Zhai Er-Tao; Chen Chuang-Qi; He Yu-Long
Journal:  Tumour Biol       Date:  2016-02-24

9.  Evaluation of rational extent lymphadenectomy for local advanced gastric cancer.

Authors:  Han Liang; Jingyu Deng
Journal:  Chin J Cancer Res       Date:  2016-08       Impact factor: 5.087

10.  Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.

Authors:  Jiuda Zhao; Feng Du; Yu Zhang; Jie Kan; Li Dong; Guoshuang Shen; Fangchao Zheng; Hui Chen; Junhui Zhao; Faxiang Ji; Yang Luo; Fei Ma; Ziyi Wang; Binghe Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.